Cargando…
Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective
Atopic dermatitis (AD) is a common chronic, multisystem inflammatory skin disease in pediatric patients. There has been an increase in the incidence of AD in the pediatric population of the Asia–Pacific region. Studies have shown that genetic, epigenetic, environmental and cultural factors may lead...
Autores principales: | Chu, Chia-Yu, Yao, Tsung-Chieh, Shih, I.-Hsin, Yang, Chin-Yi, Chin, Chan Lee, Ibrahim, Sabeera Begum Binti Kader, Thevarajah, Suganthi, Fon, Leong Kin, Ho, Marco Hok-Kung, Mo, Chow Chung, Yu, Chow Pok, Loo, Steven King-Fan, Luger, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984644/ https://www.ncbi.nlm.nih.gov/pubmed/36735214 http://dx.doi.org/10.1007/s13555-022-00886-9 |
Ejemplares similares
-
Treatment of atopic dermatitis with pimecrolimus – impact on quality of life
por: Lee, Hae-Hyuk, et al.
Publicado: (2007) -
Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants
por: Luger, Thomas, et al.
Publicado: (2015) -
Formulary Review of Therapeutic Alternatives for Atopic Dermatitis: Focus on Pimecrolimus
por: Weinberg, Jeffery M.
Publicado: (2005) -
Experts’ Consensus on the Use of Pimecrolimus in Atopic Dermatitis in China: A TCS-Sparing Practical Approach
por: Zhao, Zuotao, et al.
Publicado: (2022) -
Efficacy and tolerance of tacrolimus and pimecrolimus for atopic dermatitis: a meta-analysis
por: Yin, Zhiqiang, et al.
Publicado: (2011)